Harvey Partners’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.7M Sell
294,122
-25,878
-8% -$3.74M 3.27% 10
2026
Q1
$37.8M Buy
320,000
+16,000
+5% +$2.1M 3.01% 10
2025
Q4
$36.2M Buy
+304,000
New +$34.6M 3.21% 12

Other funds holding NOVT

Harvey Partners's NOVT Position: Q2 2026 in Review

Harvey Partners reduced its Novanta (NOVT) stake by 8.1% in Q2 2026, selling an estimated $3.74M and leaving 294,122 shares worth $47.7M. The position accounts for 3.27% of the portfolio, ranked #10.

Harvey Partners first reported a position in NOVT in Q4 2025 and has held it in 3 quarters since. 389 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Harvey Partners held 294,122 shares of Novanta worth $47.7M as of Q2 2026.
  • Harvey Partners sold 25,878 Novanta shares in Q2 2026, an estimated $3.74M.
  • Novanta made up 3.27% of Harvey Partners's portfolio in Q2 2026, its #10 holding.
  • Harvey Partners first reported a position in Novanta in Q4 2025 and has held it in 3 quarters since.
  • 389 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Harvey Partners's 13F filing for Q2 2026, filed 14 Aug 2026.